DUBAI, United Arab Emirates (CNN) – Two years after the initial outbreak, most people hospitalized with the corona virus at the onset of the infection still have persistent symptoms, according to a new study, which is the longest-running follow-up for those with long-lasting and Govt-19 illnesses.

In a study published in The Lancet on Wednesday, 55 percent of patients develop at least one symptom two years after the onset of Govt-19 infection, an improvement over 6 months after the procedure. 68% of patients suffer from symptoms.

Researchers at the China-Japan Friendship Hospital examined the records of 1,192 people who were admitted to Jininton Hospital in Wuhan, China, and who left the hospital between January 7 and May 29, 2020.

Patients were examined at six months, 12 months, and two years after returning home and asked for a subjective assessment of symptoms.

The evaluation process used objective clinical trials, including lung function tests, computed tomography scans, and 6-minute walk tests.

Overall, participants reported feeling unwell after two years and still experiencing symptoms of “Govit-19” such as pain, fatigue, sleep disorders and a decline in their mental health.

And patients who received strong respiratory therapy when they recovered, had more lung problems for a longer period of time.

Participants with persistent symptoms approached the physician more often than before the infection because they found it more difficult to exercise and the quality of life they lived was poorly assessed. Although most of them have returned to work, it is not clear whether they are still working at the level they were before they became ill.

Dr. Bin Kao, co-author of the study at the China-Japan Friendly Hospital, hopes that this research will encourage clinicians to ask their COVID-19 patients follow-up questions, even after an initial infection.

“It is important to continue to support the vast majority of COVID-19 sufferers and to understand how vaccines, new therapies and mutations affect the long-term health effects,” Cow said in a statement.

However, there was some limitation in the study because the researchers did not compare the results with those admitted to the hospital for reasons unrelated to “Govit-19” to see if they had long-term symptoms.

On the other hand, more than one hospital was not included in the research, so the results may not be common to all Govt-19 patients in other hospitals.

At the onset of infections, patients are now treated longer in the hospital, which can affect the duration of a person’s symptoms. Since research was conducted early on in infections, it is unclear whether the results will be the same for those infected with other mutations or vaccinated.

Dr. Tiwang Sangavi, a leading care specialist who researches chronic COVID-19 at the Mayo Clinic in Jacksonville, Florida and works with chronic COVID patients, believes that vaccine status may be involved in future long-term COVID studies.

“The only thing I know is that I can safely give the vaccine to long-term Govt patients,” said Sangavi, who was not involved in the study.

Furthermore, “Patients who have been vaccinated have less severe symptoms than those who have been vaccinated, and those who have been vaccinated have less severe symptoms of chronic Govt-19 compared with those who have not been vaccinated.”

Sanghavi hopes the study will help policymakers understand how important it is to fund long-term research on COVID-19 and to build infrastructure that best accommodates patients in the long run. People with chronic COVID-19.

Dr. Kristen Erlandsen, an assistant professor of medicine and epidemiologist at the University of Colorado, noted that patients should not be hospitalized with Covit-19 until they develop chronic symptoms, and he hopes for future research. Determine how long those who are not treated in the hospital will suffer.